FindTrial
Sign In

Expanded Access of Occlutech's Atrial Flow Regulator

Status
AVAILABLE
Phases
Unknown
Study type
Expanded Access
Source
ClinicalTrials.gov
Registry ID
NCT07421557
Enrollment
Unknown
Registered
2026-02-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Occlutech AFR use allowed per FDA's Expanded Access program.

Detailed description

Occlutech AFR use allowed per FDA's Expanded Access program. Each individual request is sent for FDA approval and the site's IRB approval per regulations.

Interventions

DEVICECatheter implantation of Occlutech AFR device

Sponsors

Occlutech International AB
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
ALL

Inclusion criteria

\-

Exclusion criteria

\-

Countries

United States

Contacts

CONTACTRamona Ruble
ramona.ruble@occlutech.com6126449990
CONTACTDistribution List Distribution List
physician.requests@occlutech.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026